An optimized peptide vaccine strategy capable of inducing multivalent CD8(+) T cell responses with potent antitumor effects

Therapeutic cancer vaccines are an attractive alternative to conventional therapies for treating malignant tumors, and successful tumor eradication depends primarily on obtaining high numbers of long-lasting tumor-reactive CD8(+) T cells. Dendritic cell (DC)-based vaccines constitute a promising app...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Hyun-Il, Jung, Soo-Hyun, Sohn, Hyun-Jung, Celis, Esteban, Kim, Tai-Gyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589052/
https://www.ncbi.nlm.nih.gov/pubmed/26451316
http://dx.doi.org/10.1080/2162402X.2015.1043504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589052/
https://www.ncbi.nlm.nih.gov/pubmed/26451316
http://dx.doi.org/10.1080/2162402X.2015.1043504

Ejemplares similares